Gitlab Inc.
For the period ended Oct 31, 2025. Filed Dec 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2025 · Filed Dec 3, 2025
GTLB$46.66-1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
| Three Months Ended October 31, 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Class B Common Stock · Additional Paid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Noncontrolling Interests · Total Stockholders’ Equity | |||||||||
| Shares · Amount · Shares · Amount | |||||||||
| Balances at July 31, 2025 | 147,834 | $— | 18,876 | $— | $2,080,759 | $(1,212,697) | $(1,511) | $45,031 | $911,582 |
| Conversion of Class B common stock to Class A common stock | 880 | — | (888) | — | — | — | — | — | — |
| Issuance of common stock related to vested exercised stock options | — | — | 593 | — | 8,182 | — | — | — | 8,182 |
| Issuance of common stock related to RSUs and PSUs vested | 979 | — | — | — | — | — | — | — | — |
| Common stock withheld related to net share settlement of equity awards | (11) | — | — | — | (529) | — | — | — | (529) |
| Charitable donation of common stock | 41 | — | — | — | 1,970 | — | — | — | 1,970 |
| Vesting of early exercised stock options | — | — | — | — | 3 | — | — | — | 3 |
| Stock-based compensation expense | — | — | — | — | 51,353 | — | — | 696 | 52,049 |
| Change in noncontrolling interest ownership | — | — | — | — | (6) | — | — | 6 | — |
| Other comprehensive income (loss) | — | — | — | — | — | — | 3,467 | 70 | 3,537 |
| Net loss | — | — | — | — | — | (8,276) | — | (521) | (8,797) |
| Balances at October 31, 2025 | 149,723 | $— | 18,581 | $— | $2,141,732 | $(1,220,973) | $1,956 | $45,282 | $967,997 |
| Three Months Ended October 31, 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Class B Common Stock · Additional Paid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Noncontrolling Interests · Total Stockholders’ Equity | |||||||||
| Shares · Amount · Shares · Amount | |||||||||
| Balances at July 31, 2024 | 136,462 | $— | 23,963 | $— | $1,833,786 | $(1,203,609) | $623 | $45,026 | $675,826 |
| Conversion of Class B common stock to Class A common stock | 3,255 | — | (3,255) | — | — | — | — | — | — |
| Issuance of common stock related to vested exercised stock options | — | — | 847 | — | 7,830 | — | — | — | 7,830 |
| Issuance of common stock related to RSUs vested | 758 | — | — | — | — | — | — | — | — |
| Charitable donation of common stock | 53 | — | — | — | 2,957 | — | — | — | 2,957 |
| Vesting of early exercised stock options | — | — | — | — | 78 | — | — | — | 78 |
| Stock-based compensation expense | — | — | — | — | 47,002 | — | — | 1,040 | 48,042 |
| Other comprehensive loss | — | — | — | — | — | — | (5,721) | 611 | (5,110) |
| Net income (loss) | — | — | — | — | — | 29,103 | — | (1,298) | 27,805 |
| Balances at October 31, 2024 | 140,528 | $— | 21,555 | $— | $1,891,653 | $(1,174,506) | $(5,098) | $45,379 | $757,428 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
Condensed Consolidated Statements of Stockholders’ Equity
| Nine Months Ended October 31, 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Class B Common Stock · Additional Paid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Noncontrolling Interests · Total Stockholders’ Equity | |||||||||
| Shares · Amount · Shares · Amount | |||||||||
| Balances at January 31, 2025 | 144,444 | $— | 19,469 | $— | $1,952,031 | $(1,167,614) | $(8,508) | $45,397 | $821,306 |
| Conversion of Class B common stock to Class A common stock | 2,114 | — | (2,122) | — | — | — | — | — | — |
| Issuance of common stock related to vested exercised stock options | — | — | 1,235 | — | 15,471 | — | — | — | 15,471 |
| Issuance of common stock under employee stock purchase plan | 256 | — | — | — | 8,404 | — | — | — | 8,404 |
| Repurchases, net of early exercised stock options | — | — | (1) | — | — | — | — | — | — |
| Issuance of common stock related to RSUs and PSUs vested | 2,797 | — | — | — | — | — | — | — | — |
| Common stock withheld related to net share settlement of equity awards | (11) | — | — | — | (529) | — | — | — | (529) |
| Charitable donation of common stock | 123 | — | — | — | 5,496 | — | — | — | 5,496 |
| Vesting of early exercised stock options | — | — | — | — | 56 | — | — | — | 56 |
| Stock-based compensation expense | — | — | — | — | 160,711 | — | — | 1,449 | 162,160 |
| Change in noncontrolling interest ownership | — | — | — | — | 92 | — | — | (92) | — |
| Other comprehensive income | — | — | — | — | — | — | 10,464 | 220 | 10,684 |
| Net loss | — | — | — | — | — | (53,359) | — | (1,692) | (55,051) |
| Balances at October 31, 2025 | 149,723 | $— | 18,581 | $— | $2,141,732 | $(1,220,973) | $1,956 | $45,282 | $967,997 |
| Nine Months Ended October 31, 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Class B Common Stock · Additional Paid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Noncontrolling Interests · Total Stockholders’ Equity | |||||||||
| Shares · Amount · Shares · Amount | |||||||||
| Balances at January 31, 2024 | 114,670 | $— | 42,887 | $— | $1,718,661 | $(1,161,288) | $2,398 | $46,621 | $606,392 |
| Conversion of Class B common stock to Class A common stock | 23,110 | — | (23,110) | — | — | — | — | — | — |
| Issuance of common stock related to vested exercised stock options | — | — | 1,778 | — | 17,904 | — | — | — | 17,904 |
| Issuance of common stock under employee stock purchase plan | 252 | — | — | — | 7,932 | — | — | — | 7,932 |
| Issuance of common stock related to RSUs vested | 2,323 | — | — | — | — | — | — | — | — |
| Charitable donation of common stock | 173 | — | — | — | 8,871 | — | — | — | 8,871 |
| Vesting of early exercised stock options | — | — | — | — | 267 | — | — | — | 267 |
| Stock-based compensation expense | — | — | — | — | 138,427 | — | — | 836 | 139,263 |
| Change in noncontrolling interest ownership | — | — | — | — | (409) | — | — | 409 | — |
| Other comprehensive loss | — | — | — | — | — | — | (7,496) | (271) | (7,767) |
| Net loss | — | — | — | — | — | (13,218) | — | (2,216) | (15,434) |
| Balances at October 31, 2024 | 140,528 | $— | 21,555 | $— | $1,891,653 | $(1,174,506) | $(5,098) | $45,379 | $757,428 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.